Detected ·
TidalSense
$19M—
TidalSense, a Cambridge-based AI-powered respiratory diagnostics company, has secured $19M in funding to accelerate commercialization of its N-Tidal Diagnose platform — a 75-second breath test for COPD detection — bringing total funding to $40M. The round was led by Cross-Border Impact Ventures alongside returning investors BGF, Airstream Capital, and Foresight Group.
- Website
- www.tidalsense.com
- linkedin.com/company/tidalsense
- Amount
- $19 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-24 20:03:10 UTC
- Signal ID
- 900044d5-dda3-40e1-8c5e-083dac71b653
As the API returns it
{
"id": "900044d5-dda3-40e1-8c5e-083dac71b653",
"created_at": "2026-07-24T20:03:10.633990Z",
"company_name": "TidalSense",
"company_website_url": "www.tidalsense.com",
"company_linkedin_url": "https://www.linkedin.com/company/tidalsense",
"event_type": "funding",
"funding_amount": 19000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*TidalSense, a Cambridge-based AI-powered respiratory diagnostics company, has secured $19M in funding to accelerate commercialization of its N-Tidal Diagnose platform — a 75-second breath test for COPD detection — bringing total funding to $40M. The round was led by Cross-Border Impact Ventures alongside returning investors BGF, Airstream Capital, and Foresight Group.*"
}